CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $289,000 | -1.0% | 1,673,218 | 0.0% | 0.19% | -0.5% |
| Q3 2017 | $292,000 | -24.0% | 1,673,218 | 0.0% | 0.19% | -32.2% |
| Q2 2017 | $384,000 | -29.7% | 1,673,218 | -20.4% | 0.28% | -21.6% |
| Q1 2017 | $546,000 | 0.0% | 2,101,626 | 0.0% | 0.35% | -12.9% |
| Q4 2016 | $546,000 | +21.1% | 2,101,626 | 0.0% | 0.40% | +11.0% |
| Q3 2016 | $451,000 | +26.3% | 2,101,626 | -0.2% | 0.36% | +22.1% |
| Q1 2016 | $357,000 | +12.6% | 2,104,826 | 0.0% | 0.30% | +13.7% |
| Q4 2015 | $317,000 | -55.7% | 2,104,826 | 0.0% | 0.26% | -41.3% |
| Q3 2015 | $716,000 | -5.4% | 2,104,826 | 0.0% | 0.45% | -27.5% |
| Q2 2015 | $757,000 | -47.1% | 2,104,826 | -50.0% | 0.62% | +0.7% |
| Q1 2015 | $1,432,000 | +126.6% | 4,209,652 | +100.0% | 0.61% | +20.8% |
| Q4 2014 | $632,000 | +19.7% | 2,104,826 | 0.0% | 0.51% | +60.6% |
| Q3 2014 | $528,000 | +14.5% | 2,104,826 | +81.3% | 0.32% | +20.7% |
| Q2 2014 | $461,000 | -57.5% | 1,161,282 | -45.9% | 0.26% | -58.0% |
| Q1 2014 | $1,084,000 | +46.5% | 2,146,766 | -0.0% | 0.62% | -39.4% |
| Q4 2013 | $740,000 | +21.7% | 2,147,666 | -1.1% | 1.02% | +18.9% |
| Q3 2013 | $608,000 | +32.8% | 2,171,685 | -0.4% | 0.86% | +13.4% |
| Q2 2013 | $458,000 | – | 2,181,449 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |